These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15069775)

  • 21. The future of clinical research in breast cancer: opportunities.
    Sledge GW
    Clin Breast Cancer; 2000 Jul; 1(2):95. PubMed ID: 11899657
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of antiretroviral drug resistance.
    Wainberg MA; Zaharatos GJ; Brenner BG
    N Engl J Med; 2011 Aug; 365(7):637-46. PubMed ID: 21848464
    [No Abstract]   [Full Text] [Related]  

  • 23. Lessons learned fighting HIV can be applied to anti-cancer drug design.
    Gustchina A; Jaskólski M; Wlodawer A
    Cell Cycle; 2006 Mar; 5(5):463-4. PubMed ID: 16479175
    [No Abstract]   [Full Text] [Related]  

  • 24. What are the challenges in pediatric oncology?
    Voûte PA
    Med Pediatr Oncol; 2002 Oct; 39(4):469-71. PubMed ID: 12203666
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiretroviral drug treatment of CNS HIV-1 infection.
    Yilmaz A; Price RW; Gisslén M
    J Antimicrob Chemother; 2012 Feb; 67(2):299-311. PubMed ID: 22160207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Present and future of therapeutic oncology].
    García G; Beltrán-Ortega A; Díaz-Perches R; de la Garza-Salazar JG; Noriega-Limón J; Jiménez-Zamudio L
    Gac Med Mex; 1984; 120(7-8):281-300. PubMed ID: 6526215
    [No Abstract]   [Full Text] [Related]  

  • 28. New approaches to drug development in pediatric oncology.
    Adamson PC; Blaney SM
    Cancer J; 2005; 11(4):324-30. PubMed ID: 16197722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of analytic methods for biomarkers used in drug development.
    Chau CH; Rixe O; McLeod H; Figg WD
    Clin Cancer Res; 2008 Oct; 14(19):5967-76. PubMed ID: 18829475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transport Barriers and Oncophysics in Cancer Treatment.
    Nizzero S; Ziemys A; Ferrari M
    Trends Cancer; 2018 Apr; 4(4):277-280. PubMed ID: 29606312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of first-line antiretroviral therapy and acquired drug resistance among HIV-1-infected children in India.
    Shet A; Neogi U; Sahoo PN; De Costa A
    Pediatr Infect Dis J; 2013 May; 32(5):e227-9. PubMed ID: 23249907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients.
    Welz T; Wyen C; Hensel M
    Oncol Res Treat; 2017; 40(3):120-127. PubMed ID: 28253501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New science-based endpoints to accelerate oncology drug development.
    Kelloff GJ; Sigman CC
    Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacology of antiretroviral agents in children].
    Treluyer JM
    Arch Pediatr; 2005 Jun; 12(6):684-5. PubMed ID: 15904770
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-drug interactions involving new antiretroviral drugs and drug classes.
    Soodalter J; Sousa M; Boffito M
    Curr Opin Infect Dis; 2009 Feb; 22(1):18-27. PubMed ID: 19532077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring adherence to HIV antiretroviral therapy in routine clinical practice: The past, the present, and the future.
    Bangsberg DR
    AIDS Behav; 2006 May; 10(3):249-51. PubMed ID: 16783537
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV DART 2004--frontiers in drug development for antiretroviral therapies. 12-16 December 2004, Montego Bay, Jamaica.
    Lori F
    IDrugs; 2005 Feb; 8(2):97-9. PubMed ID: 15696405
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antiretroviral therapy in 2004].
    Jablonowski H
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in drug development: off-label drug utilization in oncology.
    de Souza JA
    Clin Adv Hematol Oncol; 2011 Jun; 9(6):473-5. PubMed ID: 21841748
    [No Abstract]   [Full Text] [Related]  

  • 40. [HIV-1 protease inhibitors: cell metabolism and drug resistance (review)].
    Bobkova MR
    Ter Arkh; 2008; 80(10):77-80. PubMed ID: 19105421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.